Real-time enrollment status for this non-alcoholic fatty liver disease clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:10 PM UTC
| NCT Number | NCT07221188 |
| Recruiting Status | Recruiting |
| Condition | Non-alcoholic Fatty Liver Disease |
| Phase | PHASE3 |
| Target Enrollment | 1,250 participants |
| Active Locations | 58 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | September 17, 2026 (Sep 17, 2026) |
As of October 21, 2026: Clinical trial NCT07221188 is currently recruiting participants. This phase3 study for non-alcoholic fatty liver disease is actively seeking new participants at 58 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07221188 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 58 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07221188 was last updated Sep 17, 2026 (September 17, 2026). HelloStudys verifies this status automatically.